Rochon-Duvigneaud's syndrome
Rochon-Duvigneaud's syndrome is a rare neurological disorder characterized by a combination of symptoms including anisocoria, ptosis, and ophthalmoplegia. It is named after the French ophthalmologist Alexis Rochon and the French neurologist Jean Duvigneaud who first described the condition in the early 20th century.
Symptoms and Signs[edit | edit source]
The primary symptoms of Rochon-Duvigneaud's syndrome include anisocoria, which is a condition where the patient's pupils are of unequal size; ptosis, which is a drooping or falling of the upper eyelid; and ophthalmoplegia, which is a paralysis or weakness of the eye muscles. Other symptoms may include diplopia (double vision), mydriasis (dilated pupils), and exophthalmos (bulging eyes).
Causes[edit | edit source]
Rochon-Duvigneaud's syndrome is caused by a lesion in the sympathetic nervous system, specifically in the cervical sympathetic chain. This chain is a part of the autonomic nervous system that controls functions such as the dilation of the pupils and the lifting of the eyelid. The exact cause of the lesion is often unknown, but it can be due to trauma, tumor, or infection.
Diagnosis[edit | edit source]
Diagnosis of Rochon-Duvigneaud's syndrome is primarily based on the clinical presentation of the patient. A detailed neurological examination is performed to assess the patient's symptoms. Additional tests such as magnetic resonance imaging (MRI) or computed tomography (CT) scan may be used to identify the location and cause of the lesion.
Treatment[edit | edit source]
Treatment of Rochon-Duvigneaud's syndrome is aimed at addressing the underlying cause of the lesion. This may involve surgery to remove a tumor, antibiotics to treat an infection, or other treatments as appropriate. In some cases, no treatment is necessary if the symptoms are mild and do not interfere with the patient's daily life.
Prognosis[edit | edit source]
The prognosis for Rochon-Duvigneaud's syndrome varies depending on the underlying cause of the condition. In some cases, the symptoms may resolve on their own without treatment. In other cases, the condition may be chronic and require ongoing management.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Rochon-Duvigneaud's syndrome is a rare disease.
| Rochon-Duvigneaud's syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
